Korea University Hospital

Seoul 02841

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, Colorectal Cancer (CRC), Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors — Running, not enrolling
• A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment — Running, not enrolling